Intra-arterial Magnesium Administration for Acute Stroke

Completed

Phase 1/2 Results N/A

Summary of Purpose

Stroke is the second leading cause of death and the leading cause of adult disability worldwide. This investigation will address the safety and feasibility of directed, intra-arterial Magnesium measurement and therapy, through endovascular access, in acute stroke patients. The proposal represents the first study to directly quantify levels of a systemically administered neuroprotectant in the region of cerebral...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 May 2016.

1 Mar 2012 22 Dec 2011 1 May 2016 1 May 2016 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • William J Mack, MD